Moreover, even though the CPGs recommend against the dual blockade of the renin-angiotensin system due to excessive risk of hyperkalaemia, hypotension, and renal failure18,43, a small percentage of our patients were on ACE inhibitor and ARB combination therapy. Here, ACE is linked to Hyperkalemia.